{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:41:35Z","timestamp":1784137295299,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41431-025-01967-x","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:25:08Z","timestamp":1761049508000},"page":"1596-1605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A missense variant in the KH0-domain of FMRP downregulates the protein in a patient with the clinical hallmarks of fragile X syndrome"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1888-9066","authenticated-orcid":false,"given":"Claudio Peter","family":"D\u2019Incal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vingerhoets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7519-0246","authenticated-orcid":false,"given":"Mieke","family":"van Haelst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0346-7063","authenticated-orcid":false,"given":"Dale John","family":"Annear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-2943","authenticated-orcid":false,"given":"Anke","family":"Van Dijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Bastini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Konings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Elinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2655-3581","authenticated-orcid":false,"given":"Ligia","family":"Mateiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8149-8645","authenticated-orcid":false,"given":"Agnies M.","family":"van Eeghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-0485","authenticated-orcid":false,"given":"R. Frank","family":"Kooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"1967_CR1","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB, Moine H, Kooy RF, et al. Fragile X syndrome. Nat Rev Dis Prim. 2017;3:17065.","journal-title":"Nat Rev Dis Prim"},{"key":"1967_CR2","first-page":"60","volume":"156","author":"MJ Salcedo-Arellano","year":"2020","unstructured":"Salcedo-Arellano MJ, Hagerman RJ, Mart\u00ednez-Cerde\u00f1o V. Fragile X syndrome: clinical presentation, pathology and treatment. Gac Med Mex. 2020;156:60\u20136.","journal-title":"Gac Med Mex"},{"key":"1967_CR3","first-page":"e21840","volume":"14","author":"M Davidson","year":"2022","unstructured":"Davidson M, Sebastian SA, Benitez Y, Desai S, Quinonez J, Ruxmohan S, et al. Behavioral problems in fragile X syndrome: a review of clinical management. Cureus. 2022;14:e21840.","journal-title":"Cureus"},{"key":"1967_CR4","doi-asserted-by":"crossref","unstructured":"Tabolacci E, Nobile V, Pucci C, Chiurazzi P. Mechanisms of the FMR1 repeat instability: how does the CGG sequence expand? Int J Mol Sci. 2022;23:5425.","DOI":"10.3390\/ijms23105425"},{"key":"1967_CR5","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.neuron.2019.02.041","volume":"101","author":"C Bagni","year":"2019","unstructured":"Bagni C, Zukin RS. A synaptic perspective of fragile X syndrome and autism spectrum disorders. Neuron. 2019;101:1070\u201388.","journal-title":"Neuron"},{"key":"1967_CR6","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/hmg\/9.6.901","volume":"9","author":"P Jin","year":"2000","unstructured":"Jin P, Warren ST. Understanding the molecular basis of fragile X syndrome. Hum Mol Genet. 2000;9:901\u20138.","journal-title":"Hum Mol Genet"},{"key":"1967_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature11737","volume":"492","author":"M Ascano","year":"2012","unstructured":"Ascano M, Mukherjee N, Bandaru P, Miller JB, Nusbaum JD, Corcoran DL, et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature. 2012;492:382\u20136.","journal-title":"Nature"},{"key":"1967_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","volume":"146","author":"JC Darnell","year":"2011","unstructured":"Darnell JC, Van Driesche SJ, Zhang C, Hung KYS, Mele A, Fraser CE, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. 2011;146:247\u201361.","journal-title":"Cell"},{"key":"1967_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/hmg\/5.8.1083","volume":"5","author":"DE Eberhart","year":"1996","unstructured":"Eberhart DE, Malter HE, Feng Y, Warren ST. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet. 1996;5:1083\u201391.","journal-title":"Hum Mol Genet"},{"key":"1967_CR10","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1021\/bi034909g","volume":"42","author":"S Adinolfi","year":"2003","unstructured":"Adinolfi S, Ramos A, Martin SR, Dal Piaz F, Pucci P, Bardoni B, et al. The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding. Biochemistry. 2003;42:10437\u201344.","journal-title":"Biochemistry"},{"key":"1967_CR11","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1016\/j.jmb.2020.04.021","volume":"432","author":"YM Athar","year":"2020","unstructured":"Athar YM, Joseph S. RNA-binding specificity of the human fragile X mental retardation protein. J Mol Biol. 2020;432:3851\u201368.","journal-title":"J Mol Biol"},{"key":"1967_CR12","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/hmg\/ddq007","volume":"19","author":"E Blackwell","year":"2010","unstructured":"Blackwell E, Zhang X, Ceman S. Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA. Hum Mol Genet. 2010;19:1314\u201323.","journal-title":"Hum Mol Genet"},{"key":"1967_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0092-8674(94)90232-1","volume":"77","author":"H Siomi","year":"1994","unstructured":"Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell. 1994;77:33\u20139.","journal-title":"Cell"},{"key":"1967_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1006\/nbdi.1997.0142","volume":"4","author":"B Bardoni","year":"1997","unstructured":"Bardoni B, Sittler A, Shen Y, Mandel JL. Analysis of domains affecting intracellular localization of the FMRP protein. Neurobiol Dis. 1997;4:329\u201336.","journal-title":"Neurobiol Dis"},{"key":"1967_CR15","doi-asserted-by":"publisher","first-page":"117728","DOI":"10.1016\/j.cca.2023.117728","volume":"553","author":"A Hnoonual","year":"2024","unstructured":"Hnoonual A, Plong-On O, Worachotekamjorn J, Charalsawadi C, Limprasert P. Clinical and molecular characteristics of FMR1 microdeletion in patient with fragile X syndrome and review of the literature. Clin Chim Acta. 2024;553:117728.","journal-title":"Clin Chim Acta"},{"key":"1967_CR16","doi-asserted-by":"crossref","unstructured":"Quartier A, Poquet H, Gilbert-Dussardier B, Rossi M, Casteleyn A-S, des Portes V des, et al. Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome. Eur J Hum Genet. 2017;25:423\u201331.","DOI":"10.1038\/ejhg.2016.204"},{"key":"1967_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.mcp.2014.08.003","volume":"28","author":"M Handt","year":"2014","unstructured":"Handt M, Epplen A, Hoffjan S, Mese K, Epplen JT, Dekomien G. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening. Mol Cell Probes. 2014;28:279\u201383.","journal-title":"Mol Cell Probes"},{"key":"1967_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ajmg.a.38504","volume":"176","author":"AF Sitzmann","year":"2018","unstructured":"Sitzmann AF, Hagelstrom RT, Tassone F, Hagerman RJ, Butler MG. Rare FMR1 gene mutations causing fragile X syndrome: a review. Am J Med Genet A. 2018;176:11\u20138.","journal-title":"Am J Med Genet A"},{"key":"1967_CR19","doi-asserted-by":"crossref","unstructured":"Jones JR. Nonrandom X chromosome inactivation detection. Curr Protoc Hum Genet. 2014;80:Unit 9.7.","DOI":"10.1002\/0471142905.hg0907s80"},{"key":"1967_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65608-x","volume":"14","author":"CP D\u2019Incal","year":"2024","unstructured":"D\u2019Incal CP, Cappuyns E, Choukri K, De Man K, Szrama K, Konings A, et al. Tracing the invisible mutant ADNP protein in Helsmoortel-Van der Aa syndrome patients. Sci Rep. 2024;14:14710.","journal-title":"Sci Rep"},{"key":"1967_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40478-024-01743-w","volume":"12","author":"C D\u2019Incal","year":"2024","unstructured":"D\u2019Incal C, Van Dijck A, Ibrahim J, De Man K, Bastini L, Konings A, et al. ADNP dysregulates methylation and mitochondrial gene expression in the cerebellum of a Helsmoortel-Van der Aa syndrome autopsy case. Acta Neuropathol Commun. 2024;12:62.","journal-title":"Acta Neuropathol Commun"},{"key":"1967_CR22","doi-asserted-by":"publisher","first-page":"101075","DOI":"10.1016\/j.gim.2024.101075","volume":"26","author":"J Kerkhof","year":"2024","unstructured":"Kerkhof J, Rastin C, Levy MA, Relator R, McConkey H, Demain L, et al. Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases. Genet Med. 2024;26:101075.","journal-title":"Genet Med"},{"key":"1967_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/hmg\/2.4.399","volume":"2","author":"AJ Verkerk","year":"1993","unstructured":"Verkerk AJ, de Graaff E, De Boulle K, Eichler EE, Konecki DS, Reyniers E, et al. Alternative splicing in the fragile X gene FMR1. Hum Mol Genet. 1993;2:399\u2013404.","journal-title":"Hum Mol Genet"},{"key":"1967_CR24","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/ajmg.a.38348","volume":"173","author":"L Gieldon","year":"2017","unstructured":"Gieldon L, Mackenroth L, Betcheva-Krajcir E, Rump A, Beck-W\u00f6dl S, Schallner J, et al. Skewed X-inactivation in a family with DLG3-associated X-linked intellectual disability. Am J Med Genet A. 2017;173:2545\u201350.","journal-title":"Am J Med Genet A"},{"key":"1967_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ajmg.a.20160","volume":"122A","author":"D Heine-Su\u00f1er","year":"2003","unstructured":"Heine-Su\u00f1er D, Torres-Juan L, Morl\u00e0 M, Busquets X, Barcel\u00f3 F, Pic\u00f3 G, et al. Fragile-X syndrome and skewed X-chromosome inactivation within a family: a female member with complete inactivation of the functional X chromosome. Am J Med Genet A. 2003;122A:108\u201314.","journal-title":"Am J Med Genet A"},{"key":"1967_CR26","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/hmg\/ddu586","volume":"24","author":"LK Myrick","year":"2015","unstructured":"Myrick LK, Hashimoto H, Cheng X, Warren ST. Human FMRP contains an integral tandem Agenet (Tudor) and KH motif in the amino terminal domain. Hum Mol Genet. 2015;24:1733\u201340.","journal-title":"Hum Mol Genet"},{"key":"1967_CR27","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1523\/JNEUROSCI.5057-11.2012","volume":"32","author":"VC Nalavadi","year":"2012","unstructured":"Nalavadi VC, Muddashetty RS, Gross C, Bassell GJ. Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation. J Neurosci. 2012;32:2582\u20137.","journal-title":"J Neurosci"},{"key":"1967_CR28","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/cercor\/bhz029","volume":"29","author":"CEM Golden","year":"2019","unstructured":"Golden CEM, Breen MS, Koro L, Sonar S, Niblo K, Browne A, et al. Deletion of the KH1 domain of Fmr1 leads to transcriptional alterations and attentional deficits in rats. Cereb Cortex. 2019;29:2228\u201344.","journal-title":"Cereb Cortex"},{"key":"1967_CR29","first-page":"139","volume":"3","author":"J Diaz","year":"2018","unstructured":"Diaz J, Scheiner C, Leon E. Presentation of a recurrent FMR1 missense mutation (R138Q) in an affected female. Transl Sci. Rare Dis. 2018;3:139\u201344.","journal-title":"Rare Dis"},{"key":"1967_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.expneurol.2004.05.039","volume":"189","author":"M Schrier","year":"2004","unstructured":"Schrier M, Severijnen L-A, Reis S, Rife M, van\u2019t Padje S, van Cappellen G, et al. Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells. Exp Neurol. 2004;189:343\u201353.","journal-title":"Exp Neurol"},{"key":"1967_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng0193-31","volume":"3","author":"K De Boulle","year":"1993","unstructured":"De Boulle K, Verkerk AJ, Reyniers E, Vits L, Hendrickx J, Van Roy B, et al. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet. 1993;3:31\u20135.","journal-title":"Nat Genet"},{"key":"1967_CR32","doi-asserted-by":"publisher","first-page":"e1000758","DOI":"10.1371\/journal.pgen.1000758","volume":"5","author":"JB Zang","year":"2009","unstructured":"Zang JB, Nosyreva ED, Spencer CM, Volk LJ, Musunuru K, Zhong R, et al. A mouse model of the human Fragile X syndrome I304N mutation. PLoS Genet. 2009;5:e1000758.","journal-title":"PLoS Genet"},{"key":"1967_CR33","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/ajmg.a.33626","volume":"152A","author":"SC Collins","year":"2010","unstructured":"Collins SC, Bray SM, Suhl JA, Cutler DJ, Coffee B, Zwick ME, et al. Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males. Am J Med Genet A. 2010;152A:2512\u201320.","journal-title":"Am J Med Genet A"},{"key":"1967_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21820-1","volume":"12","author":"M Prieto","year":"2021","unstructured":"Prieto M, Folci A, Poupon G, Schiavi S, Buzzelli V, Pronot M, et al. Missense mutation of Fmr1 results in impaired AMPAR-mediated plasticity and socio-cognitive deficits in mice. Nat Commun. 2021;12:1557.","journal-title":"Nat Commun"},{"key":"1967_CR35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/ejhg.2013.311","volume":"22","author":"LK Myrick","year":"2014","unstructured":"Myrick LK, Nakamoto-Kinoshita M, Lindor NM, Kirmani S, Cheng X, Warren ST. Fragile X syndrome due to a missense mutation. Eur J Hum Genet. 2014;22:1185\u20139.","journal-title":"Eur J Hum Genet"},{"key":"1967_CR36","doi-asserted-by":"publisher","first-page":"145298","DOI":"10.1016\/j.gene.2020.145298","volume":"768","author":"S Zeidler","year":"2021","unstructured":"Zeidler S, Severijnen LA, de Boer H, van der Toorn EC, Ruivenkamp CAL, Bijlsma EK, et al. A missense variant in the nuclear export signal of the FMR1 gene causes intellectual disability. Gene. 2021;768:145298.","journal-title":"Gene"},{"key":"1967_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.stemcr.2014.10.015","volume":"4","author":"T Halevy","year":"2015","unstructured":"Halevy T, Czech C, Benvenisty N. Molecular mechanisms regulating the defects in fragile X syndrome neurons derived from human pluripotent stem cells. Stem Cell Rep. 2015;4:37\u201346.","journal-title":"Stem Cell Rep"},{"key":"1967_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","volume":"65","author":"AJ Verkerk","year":"1991","unstructured":"Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905\u201314.","journal-title":"Cell"},{"key":"1967_CR39","doi-asserted-by":"publisher","first-page":"110659","DOI":"10.1016\/j.clinbiochem.2023.110659","volume":"121\u2013122","author":"MHY Bekheet","year":"2023","unstructured":"Bekheet MHY, Mansour LA, Elkaffas RH, Kamel MA, Elmonem MA. Serum matrix metalloproteinase-9 (MMP9) and amyloid-beta protein precursor (APP) as potential biomarkers in children with Fragile-X syndrome: a cross sectional study. Clin Biochem. 2023;121\u2013122:110659.","journal-title":"Clin Biochem"},{"key":"1967_CR40","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s12311-022-01382-8","volume":"21","author":"B Lee","year":"2022","unstructured":"Lee B, Beuhler L, Lee HY. The primary ciliary deficits in cerebellar bergmann glia of the mouse model of fragile X syndrome. Cerebellum. 2022;21:801\u201313.","journal-title":"Cerebellum"},{"key":"1967_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.neuron.2012.12.018","volume":"77","author":"P-Y Deng","year":"2013","unstructured":"Deng P-Y, Rotman Z, Blundon JA, Cho Y, Cui J, Cavalli V, et al. FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels. Neuron. 2013;77:696\u2013711.","journal-title":"Neuron"},{"key":"1967_CR42","doi-asserted-by":"crossref","unstructured":"Pyronneau A, He Q, Hwang J-Y, Porch M, Contractor A, Zukin RS. Aberrant Rac1-cofilin signaling mediates defects in dendritic spines, synaptic function, and sensory perception in fragile X syndrome. Sci Signal. 2017;10:eaan0852.","DOI":"10.1126\/scisignal.aan0852"},{"key":"1967_CR43","doi-asserted-by":"crossref","unstructured":"Santorelli D, Troilo F, Fata F, Angelucci F, Demitri N, Giardina G, et al. Folding mechanism and aggregation propensity of the KH0 domain of FMRP and its R138Q pathological variant. Int J Mol Sci. 2022;23:12178.","DOI":"10.3390\/ijms232012178"},{"key":"1967_CR44","doi-asserted-by":"publisher","first-page":"e4690","DOI":"10.21769\/BioProtoc.4690","volume":"13","author":"Y Miao","year":"2023","unstructured":"Miao Y, Du Q, Zhang H-G, Yuan Y, Zuo Y, Zheng H. Cycloheximide (CHX) Chase Assay to Examine Protein Half-life. Bio Protoc. 2023;13:e4690.","journal-title":"Bio Protoc"},{"key":"1967_CR45","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/ejhg.2017.55","volume":"25","author":"A Jansen","year":"2017","unstructured":"Jansen A, Dieleman GC, Smit AB, Verhage M, Verhulst FC, Polderman TJC, et al. Gene-set analysis shows association between FMRP targets and autism spectrum disorder. Eur J Hum Genet. 2017;25:863\u20138.","journal-title":"Eur J Hum Genet"},{"key":"1967_CR46","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jmoldx.2024.02.007","volume":"26","author":"P Jiraanont","year":"2024","unstructured":"Jiraanont P, Zafarullah M, Sulaiman N, Espinal GM, Randol JL, Durbin-Johnson B, et al. FMR1 protein expression correlates with intelligence quotient in both peripheral blood mononuclear cells and fibroblasts from individuals with an FMR1 mutation. J Mol Diagn. 2024;26:498\u2013509.","journal-title":"J Mol Diagn"},{"key":"1967_CR47","doi-asserted-by":"crossref","unstructured":"Randol JL, Kim K, Ponzini MD, Tassone F, Falcon AK, Hagerman RJ, et al. Variation of FMRP expression in peripheral blood mononuclear cells from individuals with fragile X syndrome. Genes. 2024;15:356.","DOI":"10.3390\/genes15030356"},{"key":"1967_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/oby.23368","volume":"30","author":"T-H Choo","year":"2022","unstructured":"Choo T-H, Xu Q, Budimirovic D, Lozano R, Esler AN, Frye RE, et al. Height and BMI in fragile X syndrome: a longitudinal assessment. Obesity. 2022;30:743\u201350.","journal-title":"Obesity"}],"updated-by":[{"DOI":"10.1038\/s41431-026-02095-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000}}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01967-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01967-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01967-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:07:45Z","timestamp":1775034465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01967-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1967"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01967-x","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In this article author Bram Dierckx\u2019s family name was incorrectly written as Dierickx.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41431-026-02095-w","URL":"https:\/\/doi.org\/10.1038\/s41431-026-02095-w","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Clinical information of the 23-year-old male proband together with the 63-year-old mother with the c.500A>C (p.Gln167Pro)\n                      FMR1\n                      variant were received under informed consent from the tending clinician and was approved by the Ethics Committee of the Antwerp University Hospital, Antwerp, Belgium with reference number B300201316250. HEK293T cells were purchased from ATCC at a low passage number with consistent use of cells below a passage number of 15. LCLs were generated from peripheral blood lymphocytes donated by a consenting mother and clinicians in the laboratory of Frank Kooy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"A written informed consent for publication of the subjects with the c.500A>C (p.Gln167Pro)\n                      FMR1\n                      variant was provided by the mother and legal representative for use of photographs, biopsies and\/or X-rays for medical reasons (discussion between colleagues, teaching, or publication in scientific papers). All patient-derived cell lines were obtained under a written informed consent for publication by the patients and the tending clinicians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}